TABLE 2

Inhibition of dextromethorphan O-demethylation and atomoxetine 4-hydroxylation in CYP2D6.1, CYP2D6.10, and CYP2D6.17

All reactions were run in duplicate. Error estimates are based on the best fit of the average values obtained at each point to the Michaelis-Menten equation using nonlinear regression analysis.


Inhibitor

Ki

Ki ratio
CYP2D6.1
CYP2D6.10
CYP2D6.17
2D6.10/2D6.1
2D6.17/2D6.1
μM
Dextromethorphan O-demethylation
    Cocaine 1.15 ± 0.14 1.74 ± 0.25 9.29 ± 1.13 1.51 8.08
    (S)-Fluoxetine 1.27 ± 0.12 0.40 ± 0.05 1.73 ± 0.20 0.32 1.36
    (S)-Norfluoxetine 0.84 ± 0.14 0.34 ± 0.05 1.84 ± 0.31 0.41 2.19
    Imipramine 3.34 ± 0.28 3.70 ± 0.43 11.1 ± 0.8 1.11 3.32
    Quinidine 0.011 ± 0.001 0.051 ± 0.003 0.079 ± 0.005 4.64 7.18
    Thioridazine 0.018 ± 0.003 0.213 ± 0.017 0.166 ± 0.016 11.8 9.22
Atomoxetine 4-hydroxylation
    Cocaine 0.35 ± 0.04 0.43 ± 0.06 1.60 ± 0.21 1.23 4.57
    (S)-Fluoxetine 0.67 ± 0.07 0.49 ± 0.09 0.82 ± 0.09 0.73 1.22
    (S)-Norfluoxetine 1.04 ± 0.11 0.59 ± 0.11 1.16 ± 0.13 0.57 1.12
    Imipramine 3.04 ± 0.34 4.26 ± 0.43 7.64 ± 0.64 1.40 2.51
    Quinidine 0.010 ± 0.001 0.023 ± 0.002 0.056 ± 0.007 2.30 5.60
    Thioridazine
0.026 ± 0.002
0.494 ± 0.090
0.103 ± 0.009
19.0
3.96